TABLE 1.
pMMR | ||||||
---|---|---|---|---|---|---|
Characteristic (n = 107) | Right‐sided (n = 24) | % | Left‐sided (n = 83) | % | Total | P value |
Sex | ||||||
Male | 15 | 63 | 56 | 67 | 71 | .0652 |
Female | 9 | 38 | 27 | 33 | 36 | |
Age (y), median (range) | ||||||
≤70 | 8 | 33 | 51 | 61 | 59 | .0145* |
>70 | 16 | 67 | 32 | 39 | 48 | |
Tumor depth | ||||||
T1‐2 | 2 | 8 | 7 | 8 | 9 | .9875 |
T3‐4 | 22 | 92 | 76 | 92 | 98 | |
Lymph node metastasis | ||||||
Negative | 17 | 71 | 40 | 48 | 57 | .0470* |
Positive | 7 | 29 | 43 | 52 | 50 | |
Tumor differentiation | ||||||
Well/moderate | 21 | 88 | 73 | 88 | 94 | .9526 |
Others | 3 | 12 | 10 | 12 | 13 | |
Lymphatic invasion | ||||||
Negative | 12 | 50 | 35 | 42 | 47 | .4971 |
Positive | 12 | 50 | 48 | 58 | 60 | |
Venous invasion | ||||||
Negative | 5 | 21 | 20 | 24 | 29 | .7370 |
Positive | 19 | 79 | 63 | 76 | 88 | |
Perineural invasion | ||||||
Negative | 20 | 83 | 64 | 77 | 84 | .5039 |
Positive | 4 | 17 | 19 | 23 | 23 | |
Adjuvant chemotherapy | ||||||
No | 17 | 71 | 49 | 59 | 66 | .2885 |
Yes | 7 | 29 | 34 | 41 | 41 | |
Recurrence | ||||||
No | 8 | 33 | 23 | 28 | 33 | .5963 |
Yes | 16 | 67 | 60 | 72 | 84 |
P < .05